Stay updated on Prophylactic Emicizumab in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.

Latest updates to the Prophylactic Emicizumab in Hemophilia A Clinical Trial page
- Check2 days agoChange DetectedNotice: A government-funding lapse notice with open NIH Clinical Center status and a revision to v3.4.1 were added, and the reference to v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check9 days agoChange DetectedThe changes are minor UI and metadata updates (glossary toggle, capitalization adjustments to QC criteria labels, and a new version label) that do not affect study content or core page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check44 days agoChange DetectedAdded a comprehensive list of study locations (California, Colorado, Georgia, Massachusetts, Michigan, New York, Oregon, Pennsylvania, Texas, Washington; New South Wales, Victoria; Lombardy, Tuscany) and updated to revision v3.3.3. The previous location headers (e.g., California Locations) and the HHS Vulnerability Disclosure link were removed in the prior revision 3.3.2.SummaryDifference1%

- Check66 days agoChange Detected- Page revision updated from v3.3.1 to v3.3.2. No substantive changes to study details or navigation are evident.SummaryDifference0.0%

- Check73 days agoChange DetectedPublications section is updated to indicate items are automatically filled from PubMed and may not be about the study, and the page now shows Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedRemoved the government funding status notice from the page; core study content such as eligibility, endpoints, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Prophylactic Emicizumab in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.